Global Nutraceuticals CDMO Industry Research 2024: Size, Share, Trends, Opportunity, and Competitive Landscape, 2019-2029F
22 juil. 2024 04h46 HE
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE®
18 juil. 2024 01h30 HE
|
CROSSJECT
Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui complète les résultats satisfaisants obtenus avec les lots précédents dans le...
Crossject achieves key ZEPIZURE® manufacturing milestone
18 juil. 2024 01h30 HE
|
CROSSJECT
Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying results from previous batches under stability studies, and is...
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
11 juil. 2024 08h00 HE
|
Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
Small Molecule Innovator CDMO Research Report 2024: Global Market Set to Reach US$86.247 Billion by 2029 - Government Initiatives Fueling Expansion, Addressing Chronic Disease Predominance
10 juil. 2024 06h34 HE
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator CDMO Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global small...
Olon Group Announces the Acquisition of GTP Bioways Group
03 juil. 2024 04h30 HE
|
Olon SpA
OLON GROUP ANNOUNCES THE ACQUISITION
OF GTP BIOWAYS GROUP
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufa
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
02 juil. 2024 16h05 HE
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...
Europe Biologics CDMO Market Research 2023-2032: Companies that Skillfully Navigate Regulatory Complexities and Adopt Technological Innovations are Well-Positioned for Significant Success
01 juil. 2024 05h09 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Biologics CDMO Market: Focus on Cell Type, Molecule Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ...
Nucleic Acid Therapeutics CDMO Market Research Report 2024-2034 Featuring Strategic Analysis of Lonza Group, Catalent, and Thermo Fisher Scientific Among Others
28 juin 2024 10h23 HE
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Nucleic Acid Therapeutics CDMO Market" report has been added to ResearchAndMarkets.com's offering.The global nucleic acid therapeutics CDMO...
Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management
27 juin 2024 09h00 HE
|
Blue Mountain
Blue Mountain and Zifo announce a partnership to enhance efficiency and innovation in the life sciences sector, offering advanced solutions for GMP.